Production (Stage)
Thermo Fisher Scientific Inc.
TMO
$393.66
-$6.82-1.70%
NYSE
03/29/2025 | 12/31/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 5.95B | 5.57B | 6.65B | 8.82B | 7.25B |
Total Receivables | 9.82B | 9.63B | 9.80B | 9.43B | 9.35B |
Inventory | 5.22B | 4.98B | 5.43B | 5.20B | 5.13B |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 2.39B | 1.96B | 1.91B | 2.03B | 1.90B |
Total Current Assets | 23.38B | 22.14B | 23.78B | 25.48B | 23.64B |
|
|||||
Total Current Assets | 23.38B | 22.14B | 23.78B | 25.48B | 23.64B |
Net Property, Plant & Equipment | 9.33B | 10.80B | 9.41B | 9.28B | 9.32B |
Long-term Investments | 46.49B | 45.85B | 46.73B | 43.84B | 43.84B |
Goodwill | 46.49B | 45.85B | 46.73B | 43.84B | 43.84B |
Total Other Intangibles | 15.32B | 31.10B | 16.26B | 15.52B | 16.05B |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 4.16B | 5.45B | 4.09B | 3.90B | 4.02B |
Total Assets | 99.04B | 97.32B | 100.36B | 98.50B | 97.10B |
|
|||||
Total Accounts Payable | 3.05B | 3.08B | 2.61B | 2.55B | 2.56B |
Total Accrued Expenses | 4.38B | 4.88B | 5.16B | 4.46B | 4.25B |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.82B | 2.48B | 4.12B | 5.12B | 4.45B |
Total Finance Division Other Current Liabilities | 2.93B | 2.90B | 2.72B | 2.64B | 2.68B |
Total Other Current Liabilities | 2.93B | 2.90B | 2.72B | 2.64B | 2.68B |
Total Current Liabilities | 13.17B | 13.33B | 14.60B | 14.77B | 13.94B |
|
|||||
Total Current Liabilities | 13.17B | 13.33B | 14.60B | 14.77B | 13.94B |
Long-Term Debt | 31.24B | 28.93B | 31.20B | 30.10B | 31.00B |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 200.00M | 1.43B | 200.00M | 207.00M | 215.00M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 4.94B | 3.96B | 5.27B | 5.88B | 6.32B |
Total Liabilities | 49.56B | 47.65B | 51.27B | 50.96B | 51.47B |
|
|||||
Common Stock & APIC | 18.56B | 18.41B | 18.28B | 18.09B | 17.93B |
Retained Earnings | 54.45B | 53.10B | 51.42B | 49.94B | 48.54B |
Treasury Stock & Other | -23.61B | -21.92B | -20.70B | -20.60B | -20.95B |
Total Common Equity | 49.39B | 49.58B | 48.99B | 47.43B | 45.52B |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 49.39B | 49.58B | 48.99B | 47.43B | 45.52B |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | 95.00M | 87.00M | 107.00M | 103.00M | 107.00M |
Total Equity | 49.49B | 49.67B | 49.10B | 47.54B | 45.62B |
|